Remove Big Data Remove Doctors Remove Life Science Remove Marketing
article thumbnail

Medical Informatics: a bridge between two worlds

pharmaphorum

Her research area is the secondary use of observational data of patients with rare and unclear diseases; with attention to the research data infrastructure and terminologies. In 2021, she co-founded OHDSI Germany, which is as a national node of the Observational Health Data Sciences and Informatics (OHDSI) Europe. .

Genome 58
article thumbnail

Using technology to reassess the clinical trial landscape

pharmaphorum

“We can couple that with claims data and directly look at healthcare resource utilisation and see which doctors patients are visiting and if they are going to the emergency room or urgent care because of pain,” Sackman states. He oversees operations, including business development, sales and marketing, and people.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Medical Informatics and Rare Disease: a bridge between two worlds

pharmaphorum

Her research area is the secondary use of observational data of patients with rare and unclear diseases; with attention to the research data infrastructure and terminologies. In 2021, she co-founded OHDSI Germany, which is as a national node of the Observational Health Data Sciences and Informatics (OHDSI) Europe.

Genome 105
article thumbnail

New technologies fuel advancements in digital health

Pharmaceutical Technology

The global market size is estimated to be more than $95.3bn 1. Services such as Personal Health Records and diagnostic apps collect, store and analyse patient data, which assists healthcare practitioners with diagnosis as well as enabling them to create tailored treatment plans based on the needs of the patient.